Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > TLTFF- In good standing to challenge Merck’s Keytruda.

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon Sep 12, 2021 10:28am

223 Views

Post# 33846111

RE:TLTFF- In good standing to challenge Merck’s Keytruda.

Well, Mr Uddin is a lone voice in the wilderness. Ok, Dr. Sherri is also out there. Then there are the voices on this board. maybe TLT's new COO/CEO will be a good promoter, walk that fine line to not get in trouble the way RW did? Not that RW deserved to... IMO. Anyway, it is starting now at least, we should know in the next few months if this investment will pay off, as we see CR %s improve.

I agree with others, we should have a favorable buyout or JV offer within the next year or two.

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?